Premedication for fibreoptic bronchoscopy: fentanyl, diazepam, and atropine compared with papaveretum and hyoscine Fibreoptic bronchoscopy is often conducted under local anaesthetic after premedication. The acceptability of this procedure, using papaveretum and hyoscine as premedication, has been assessed.' Most patients tolerated the procedure well, but a significant proportion thought it unpleasant, and 45% experienced pain. We therefore compared premedication using fentanyl (a potent, short-acting opiate), diazepam, and atropine with that using papaveretum and hyoscine.
Patients, methods, and results
We assessed respiratory reserve in 57 patients requiring bronchoscopy.
Five patients who had a peak flow rate < 120 1/min were considered unfit for opiate premedication. The other 52 patients were randomly allocated for premedication by either fentanyl, diazepam, and atropine intravenously at the time of bronchoscopy, or papaveretum and hyoscine intramuscularly 45 minutes beforehand (table). Doses (depending on body weight) were fentanyl 50-150 ,Lg, diazepam 5-10 mg, atropine 0-6 mg, papaveretum 10-20 mg, hyoscine 0-2-0-4 mg. All patients were also given lignocaine local anaesthetic spray for nose and pharynx, followed by 2 ml of 4 % lignocaine to vocal cords, and 6 ml of 2 % lignocaine to trachea and bronchial tree. Oxygen 3 1/min was administered to all patients via nasal catheter during the procedure. A questionnaire given to patients 24 hours after bronch6scopy specifically asked about their recall of the procedure and its acceptability.
Combining fentanyl, diazepam, and atropine for premedication made the procedure more acceptable. Only one recalled pain, and only two would have preferred a general anaesthetic. Complaints of sore throats were similar between groups. The bronchoscopist's identity appeared to have no effect. More patients were amnesic with fentanyl, diazepam, and atropine, but this was not statistically significant.
Comment
This single-blind trial showed that fentanyl, diazepam, and atropine appeared to be better premedication for fibreoptic bronchoscopy than papaveretum and hyoscine. A double-blind trial was impossible because one combination was given intravenously at the time of the procedure, the other intramuscularly beforehand. Nevertheless, no patient knew which drug combination he received, not did the technician who explained the questionnaire to the patient.
Of the patients who had fentanyl, diazepam, and atropine, only 8°' would have preferred a general anaesthetic, whereas 58°, of those given papaveretum and hyoscine would have preferred one. Reasons for the disparity between our results with papaveretum and hyoscine and those of other workers are unclear'; in the earlier study, however, the questionnaire was given only 2-4 hours after the procedure when effects of opiate might still have been present.
We recommend that two doctors be present during the procedure in case of appreciable respiratory depression. Because respiratory depression occurs with both regimens we administered continuous oxygen, and respiratory function was tested to exclude patients in whom opiates should be avoided.
Fentanyl and papaveretum are equipotent for analgesia and respiratory depression, but the respiratory depression with fentanyl lasts 30 minutes (maximal 5 miflutes), a much shorter time than with other opiates.2 A secondary peak of fentanyl occurs in the serum at 45 minutes; the clinical significance of this is uncertain, but care should be taken to give a relatively small single dose of fentanyl ( < 2 1tg/kg).3 Opiates should be avoided subsequently because "rebound" respiratory depression may occur.4 Diazepam was used as a sedative because it is shorter acting than other benzodiazepines, although it has a higher incidence of local side effects. If a large antecubital vein is used, however, the incidence of painless local venous thrombosis is reduced to around 60°,.5
We consider fentanyl, diazepam, and atropine safe for outpatients, provided that they are observed for six hours. 
